{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:42:23Z","timestamp":1773412943583,"version":"3.50.1"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tianjin University of Traditional Chinese Medicine of Traditional Chinese Medicine Scientific Research Support Project"},{"DOI":"10.13039\/501100019065","name":"Tianjin Science and Technology Planning Project","doi-asserted-by":"crossref","award":["21JCQNJC01350"],"award-info":[{"award-number":["21JCQNJC01350"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin University of Traditional Chinese Medicine twelfth College Students Science and Technology Innovation Fund","award":["ZR19"],"award-info":[{"award-number":["ZR19"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00216-023-04520-1","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T09:07:35Z","timestamp":1674464855000},"page":"1589-1605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A review of the current research on in vivo and in vitro detection for alpha-synuclein: a biomarker of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"415","author":[{"given":"Rui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-chao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan-lian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"issue":"2","key":"4520_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.rbp.2012.07.002","volume":"34","author":"M Benadiba","year":"2012","unstructured":"Benadiba M, Luurtsema G, Wichert-Ana L, Buchpigel CA, Busatto FG. New molecular targets for PET and SPECT imaging in neurodegenerative diseases. Braz J Psychiatry. 2012;34(2):125\u201348. https:\/\/doi.org\/10.1016\/j.rbp.2012.07.002.","journal-title":"Braz J Psychiatry"},{"key":"4520_CR2","doi-asserted-by":"publisher","unstructured":"O\u2019 Hara DM, Kalia SK, Kalia LV. Methods for detecting toxic \u03b1-Synuclein species as a biomarker for Parkinson\u2019s disease. Crit Rev Clin Lab Sci. 2020;57(5):291\u2013307. https:\/\/doi.org\/10.1080\/10408363.2019.1711359.","DOI":"10.1080\/10408363.2019.1711359"},{"issue":"19","key":"4520_CR3","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1111\/febs.14409","volume":"285","author":"F Kundel","year":"2018","unstructured":"Kundel F, Tosatto L, Whiten DR, Wirthensohn DC, Horrocks MH, Klenerman D. Shedding light on aberrant interactions-a review of modern tools for studying protein aggregates. FEBS J. 2018;285(19):3604\u201330. https:\/\/doi.org\/10.1111\/febs.14409.","journal-title":"FEBS J"},{"issue":"66","key":"4520_CR4","doi-asserted-by":"publisher","first-page":"9107","DOI":"10.1039\/C8CC03619E","volume":"54","author":"KJ Cao","year":"2018","unstructured":"Cao KJ, Yang J. Translational opportunities for amyloid-targeting fluorophores. Chem Commun (Camb). 2018;54(66):9107\u201318. https:\/\/doi.org\/10.1039\/C8CC03619E.","journal-title":"Chem Commun (Camb)"},{"key":"4520_CR5","doi-asserted-by":"publisher","unstructured":"Han D, Zheng W, Wang X, Chen Z. Proteostasis of \u03b1-Synuclein and its role in the pathogenesis of Parkinson\u2019s disease. Front Cell Neurosci. 2020;14(45). https:\/\/doi.org\/10.3389\/fncel.2020.00045.","DOI":"10.3389\/fncel.2020.00045"},{"issue":"22","key":"4520_CR6","doi-asserted-by":"publisher","first-page":"8666","DOI":"10.3390\/ijms21228666","volume":"21","author":"D Fricova","year":"2020","unstructured":"Fricova D, Harsanyiova J, Kralova TA. Alpha-synuclein in the gastrointestinal tract as a potential biomarker for early detection of Parkinson\u2019s disease. Int J Mol Sci. 2020;21(22):8666. https:\/\/doi.org\/10.3390\/ijms21228666.","journal-title":"Int J Mol Sci"},{"key":"4520_CR7","doi-asserted-by":"publisher","unstructured":"Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD. Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease. Front Neurol. 2017; 8(37). https:\/\/doi.org\/10.3389\/fneur.2017.00037.","DOI":"10.3389\/fneur.2017.00037"},{"issue":"9","key":"4520_CR8","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.3390\/ijms19092486","volume":"19","author":"AI Sulatskaya","year":"2018","unstructured":"Sulatskaya AI, Rodina NP, Sulatsky MI, Povarova OI, Antifeeva IA, Kuznetsova IM, Turoverov KK. Investigation of \u03b1-Synuclein amyloid fibrils using the fluorescent probe thioflavin-T. Int J Mol Sci. 2018;19(9):2486. https:\/\/doi.org\/10.3390\/ijms19092486.","journal-title":"Int J Mol Sci"},{"key":"4520_CR9","doi-asserted-by":"publisher","unstructured":"Ghosh S, Sakshi, Swain BC, Chakraborty R, Tripathy U, Chattopadhyay K. A novel tool to investigate the early and late stages of \u03b1-synuclein aggregation. ACS Chem Neurosci. 2020;11(11):1610\u20131619. https:\/\/doi.org\/10.1021\/acschemneuro.0c00068.","DOI":"10.1021\/acschemneuro.0c00068"},{"key":"4520_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fphar.2020.00356","volume":"11","author":"N Granado","year":"2020","unstructured":"Granado N, G\u00f3mez-Benito M, Garc\u00eda-Sanz P, Michel A, Dumoulin M, Moratalla R. Modeling Parkinson\u2019s disease with the alpha-synuclein protein. Front Pharmacol. 2020;11:356. https:\/\/doi.org\/10.3389\/fphar.2020.00356.","journal-title":"Front Pharmacol"},{"issue":"3","key":"4520_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/13506129.2018.1517736","volume":"25","author":"A Sidhu","year":"2018","unstructured":"Sidhu A, Vaneyck J, Blum C, Segers-Nolten I, Subramaniam V. Polymorph-specific distribution of binding sites determines thioflavin-T fluorescence intensity in \u03b1-synuclein fibrils. Amyloid. 2018;25(3):189\u201396. https:\/\/doi.org\/10.1080\/13506129.2018.1517736.","journal-title":"Amyloid"},{"issue":"4","key":"4520_CR12","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3390\/molecules25040977","volume":"25","author":"BC Uzuegbunam","year":"2020","unstructured":"Uzuegbunam BC, Librizzi D, Hooshyar YB. PET radiopharmaceuticals for Alzheimer\u2019s disease and Parkinson\u2019s disease diagnosis, the current and future landscape. Molecules. 2020;25(4):977. https:\/\/doi.org\/10.3390\/molecules25040977.","journal-title":"Molecules"},{"issue":"4","key":"4520_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/13506120600960643","volume":"13","author":"C Avidan-Shpalter","year":"2006","unstructured":"Avidan-Shpalter C, Gazit E. The early stages of amyloid formation: biophysical and structural characterization of human calcitonin pre-fibrillar assemblies. Amyloid. 2006;13(4):216\u201325. https:\/\/doi.org\/10.1080\/13506120600960643.","journal-title":"Amyloid"},{"issue":"12","key":"4520_CR14","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/febs.12817","volume":"281","author":"O Tavassoly","year":"2014","unstructured":"Tavassoly O, Nokhrin S, Dmitriev OY, Lee JS. Cu (II) and dopamine bind to \u03b1-synuclein and cause large conformational changes. FEBS J. 2014;281(12):2738\u201353. https:\/\/doi.org\/10.1111\/febs.12817.","journal-title":"FEBS J"},{"issue":"3","key":"4520_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/mabi.200800242","volume":"9","author":"A Rekas","year":"2009","unstructured":"Rekas A, Lo V, Gadd GE, Cappai R, Yun SI. PAMAM dendrimers as potential agents against fibrillation of alpha-synuclein, a Parkinson\u2019s disease-related protein. Macromol Biosci. 2009;9(3):230\u20138. https:\/\/doi.org\/10.1002\/mabi.200800242.","journal-title":"Macromol Biosci"},{"key":"4520_CR16","doi-asserted-by":"publisher","unstructured":"Li X, Dong C, Hoffmann M, Garen CR, Cortez LM, Petersen NO. Woodside MT. Early stages of aggregation of engineered \u03b1-synuclein monomers and oligomers in solution. Sci Rep. 2019;11;9(1):1734. https:\/\/doi.org\/10.1038\/s41598-018-37584-6.","DOI":"10.1038\/s41598-018-37584-6"},{"issue":"52","key":"4520_CR17","doi-asserted-by":"publisher","first-page":"17069","DOI":"10.1002\/anie.201809865","volume":"57","author":"JD Flynn","year":"2018","unstructured":"Flynn JD, Jiang Z, Lee JC. Segmental 13C-labeling and raman microspectroscopy of \u03b1-synuclein amyloid formation. Angew Chem Int Ed Engl. 2018;57(52):17069\u201372. https:\/\/doi.org\/10.1002\/anie.201809865.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4520_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-61779-105-5_3","volume":"736","author":"C Canale","year":"2011","unstructured":"Canale C, Torre B, Ricci D, Braga PC. Recognizing and avoiding artifacts in atomic force microscopy imaging. Methods Mol Biol. 2011;736:31\u201343. https:\/\/doi.org\/10.1007\/978-1-61779-105-5_3.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"4520_CR19","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jmb.2005.10.012","volume":"354","author":"C McAllister","year":"2005","unstructured":"McAllister C, Karymov MA, Kawano Y, Lushnikov AY, Mikheikin A, Uversky VN, Lyubchenko YL. Protein interactions and misfolding analyzed by AFM force spectroscopy. J Mol Biol. 2005;354(5):1028\u201342. https:\/\/doi.org\/10.1016\/j.jmb.2005.10.012.","journal-title":"J Mol Biol"},{"issue":"7","key":"4520_CR20","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1021\/ja412105t","volume":"136","author":"S Campioni","year":"2014","unstructured":"Campioni S, Carret G, Jordens S, Nicoud L, Mezzenga R, Riek R. The presence of an air-water interface affects formation and elongation of \u03b1-Synuclein fibrils. J Am Chem Soc. 2014;136(7):2866\u201375. https:\/\/doi.org\/10.1021\/ja412105t.","journal-title":"J Am Chem Soc"},{"issue":"17","key":"4520_CR21","doi-asserted-by":"publisher","first-page":"10385","DOI":"10.1021\/acs.analchem.8b02226","volume":"90","author":"CG Taylor","year":"2018","unstructured":"Taylor CG, Meisl G, Horrocks MH, Zetterberg H, Knowles TPJ, Klenerman D. Extrinsic amyloid-binding dyes for detection of individual protein aggregates in solution. Anal Chem. 2018;90(17):10385\u201393. https:\/\/doi.org\/10.1021\/acs.analchem.8b02226.","journal-title":"Anal Chem"},{"issue":"16","key":"4520_CR22","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1002\/pmic.201400605","volume":"15","author":"R Beveridge","year":"2015","unstructured":"Beveridge R, Phillips AS, Denbigh L, Saleem HM, MacPhee CE, Barran PE. Relating gas phase to solution conformations: lessons from disordered proteins. Proteomics. 2015;15(16):2872\u201383. https:\/\/doi.org\/10.1002\/pmic.201400605.","journal-title":"Proteomics"},{"issue":"5","key":"4520_CR23","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1021\/acs.jproteome.8b00982","volume":"18","author":"P Bhattacharjee","year":"2019","unstructured":"Bhattacharjee P, \u00d6hrfelt A, Lashley T, Blennow K, Brinkmalm A, Zetterberg H. Mass spectrometric analysis of Lewy body-enriched \u03b1-Synuclein in Parkinson\u2019s disease. J Proteome Res. 2019;18(5):2109\u201320. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00982.","journal-title":"J Proteome Res"},{"issue":"8","key":"4520_CR24","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1021\/pr300014s","volume":"11","author":"A Prakash","year":"2012","unstructured":"Prakash A, Rezai T, Krastins B, Sarracino D, Athanas M, Russo P, Zhang H, Tian Y, Li Y, Kulasingam V, Drabovich A, Smith CR, Batruch I, Oran PE, Fredolini C, Luchini A, Liotta L, Petricoin E, Diamandis EP, Chan DW, Nelson R, Lopez MF. Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies. J Proteome Res. 2012;11(8):3986\u201395. https:\/\/doi.org\/10.1021\/pr300014s.","journal-title":"J Proteome Res"},{"issue":"3","key":"4520_CR25","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3390\/ijms13033038","volume":"13","author":"NE Pryor","year":"2012","unstructured":"Pryor NE, Moss MA, Hestekin CN. Unraveling the early events of amyloid-\u03b2 protein (A\u03b2) aggregation: techniques for the determination of A\u03b2 aggregate size. Int J Mol Sci. 2012;13(3):3038\u201372. https:\/\/doi.org\/10.3390\/ijms13033038.","journal-title":"Int J Mol Sci"},{"key":"4520_CR26","doi-asserted-by":"publisher","unstructured":"Zhang C, Woolfork AG, Suh K, Ovbude S, Bi C, Elzoeiry M, Hage DS. Clinical and pharmaceutical applications of affinity ligands in capillary electrophoresis: a review. J Pharm Biomed Anal. 2020;177:112882. https:\/\/doi.org\/10.1016\/j.jpba.2019.112882.","DOI":"10.1016\/j.jpba.2019.112882"},{"issue":"1","key":"4520_CR27","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1021\/acs.analchem.9b04802","volume":"92","author":"R Pero-Gascon","year":"2020","unstructured":"Pero-Gascon R, Benavente F, Minic Z, Berezovski MV, Sanz-Nebot V. On-line aptamer affinity solid-phase extraction capillary electrophoresis-mass spectrometry for the analysis of blood \u03b1-Synuclein. Anal Chem. 2020;92(1):1525\u201333. https:\/\/doi.org\/10.1021\/acs.analchem.9b04802.","journal-title":"Anal Chem"},{"key":"4520_CR28","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. 2019;14:5541\u201354. https:\/\/doi.org\/10.2147\/IJN.S200490.","journal-title":"Int J Nanomedicine"},{"issue":"10","key":"4520_CR29","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1001\/jamaneurol.2020.1741","volume":"77","author":"S Karanth","year":"2020","unstructured":"Karanth S, Nelson PT, Katsumata Y, Kryscio RJ, Schmitt FA, Fardo DW, Cykowski MD, Jicha GA, Van Eldik LJ, Abner EL. Prevalence and clinical phenotype of quadruple misfolded proteins in older adults. JAMA Neurol. 2020;77(10):1299\u2013307. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1741.","journal-title":"JAMA Neurol"},{"key":"4520_CR30","doi-asserted-by":"publisher","unstructured":"PP Liu, Xie Y, Meng XY, Kang JS. History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. Signal Transduct Target Ther. 2019;4:29. https:\/\/doi.org\/10.1038\/s41392-019-0063-8.","DOI":"10.1038\/s41392-019-0063-8"},{"issue":"2","key":"4520_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/mds.26480","volume":"31","author":"C Ruffmann","year":"2016","unstructured":"Ruffmann C, Parkkinen L. Gut feelings about \u03b1-synuclein in gastrointestinal biopsies: biomarker in the making? Mov Disord. 2016;31(2):193\u2013202. https:\/\/doi.org\/10.1002\/mds.26480.","journal-title":"Mov Disord"},{"key":"4520_CR32","doi-asserted-by":"publisher","unstructured":"Ruffmann C, Bengoa-Vergniory N, Poggiolini I, Ritchie D, Hu MT. Alegre-Abarrategui J, Parkkinen L. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson\u2019s disease. Neuropathol Appl Neurobiol. 2018;44(7):722-736. https:\/\/doi.org\/10.1111\/nan.12486.","DOI":"10.1111\/nan.12486"},{"key":"4520_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","volume":"1170","author":"CH Hawkes","year":"2009","unstructured":"Hawkes CH, Del Tredici K, Braak H. Parkinson\u2019s disease: the dual hit theory revisited. Ann N Y Acad Sci. 2009;1170:615\u201322. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04365.x.","journal-title":"Ann N Y Acad Sci"},{"key":"4520_CR34","doi-asserted-by":"publisher","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG. Arizona Parkinson\u2019s Disease Consortium. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010;119(6):689\u2013702. https:\/\/doi.org\/10.1007\/s00401-010-0664-3.","DOI":"10.1007\/s00401-010-0664-3"},{"issue":"11","key":"4520_CR35","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/acn3.669","volume":"5","author":"G Melli","year":"2018","unstructured":"Melli G, Vacchi E, Biemmi V, Galati S, Staedler C, Ambrosini R, Kaelin-Lang A. Cervical skin denervation associates with alpha-synuclein aggregates in Parkinson disease. Ann Clin Transl Neurol. 2018;5(11):1394\u2013407. https:\/\/doi.org\/10.1002\/acn3.669.","journal-title":"Ann Clin Transl Neurol"},{"issue":"8","key":"4520_CR36","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1093\/brain\/awv138","volume":"138","author":"L Zange","year":"2015","unstructured":"Zange L, Noack C, Hahn K, Stenzel W, Lipp A. Phosphorylated \u03b1-synuclein in skin nerve fibres differentiates Parkinson\u2019s disease from multiple system atrophy. Brain. 2015;138(8):2310\u201321. https:\/\/doi.org\/10.1093\/brain\/awv138.","journal-title":"Brain"},{"key":"4520_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2019.03.003","volume":"64","author":"A Kuzkina","year":"2019","unstructured":"Kuzkina A, Schulmeyer L, Monoranu CM, Volkmann J, Sommer C, Doppler K. The aggregation state of \u03b1-synuclein deposits in dermal nerve fibers of patients with Parkinson\u2019s disease resembles that in the brain. Parkinsonism Relat Disord. 2019;64:66\u201372. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.03.003.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"4520_CR38","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1523\/JNEUROSCI.2581-13.2014","volume":"34","author":"KJ Spinelli","year":"2014","unstructured":"Spinelli KJ, Taylor JK, Osterberg VR, Churchill MJ, Pollock E, Moore C, Meshul CK, Unni VK. Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson\u2019s disease. J Neurosci. 2014;34(6):2037\u201350. https:\/\/doi.org\/10.1523\/JNEUROSCI.2581-13.2014.","journal-title":"J Neurosci"},{"issue":"1","key":"4520_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","volume":"128","author":"K Doppler Doppler","year":"2014","unstructured":"Doppler Doppler K, Ebert S, U\u00e7eyler N, Trenkwalder C, Ebentheuer J, Volkmann J, Sommer C. Cutaneous neuropathy in Parkinson\u2019s disease: a window into brain pathology. Acta Neuropathol. 2014;128(1):99\u2013109. https:\/\/doi.org\/10.1007\/s00401-014-1284-0.","journal-title":"Acta Neuropathol"},{"key":"4520_CR40","doi-asserted-by":"publisher","unstructured":"Liu X, Yang J, Yuan Y, He Q, Gao Y, Jiang C, Li L, Xu Y. Optimization of the detection method for phosphorylated \u03b1-synuclein in Parkinson disease by skin biopsy. Front Neurol. 2020; 11: 569446.\u00a0https:\/\/doi.org\/10.3389\/fneur.2020.569446.","DOI":"10.3389\/fneur.2020.569446"},{"issue":"10","key":"4520_CR41","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/mds.26702","volume":"31","author":"L Antunes","year":"2016","unstructured":"Antunes L, Frasquilho S, Ostaszewski M, Weber J, Longhino L, Antony P, Baumuratov A, Buttini M, et al. Similar \u03b1-synuclein staining in the colon mucosa in patients with Parkinson\u2019s disease and controls. Movement Disord. 2016;31(10):1567\u201370. https:\/\/doi.org\/10.1002\/mds.26702.","journal-title":"Movement Disord"},{"issue":"2","key":"4520_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mds.25298","volume":"28","author":"A Gold","year":"2013","unstructured":"Gold A, Turkalp ZT, Munoz DG. Enteric alpha-synuclein expression is increased in Parkinson\u2019s disease but not Alzheimer\u2019s disease. Movement Disord. 2013;28(2):237\u201341. https:\/\/doi.org\/10.1002\/mds.25298.","journal-title":"Movement Disord"},{"issue":"3","key":"4520_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-018-01956-z","volume":"137","author":"L Veys","year":"2019","unstructured":"Veys L, Vandenabeele M, Ortuno-Lizaran I, Baekelandt V, Cuenca N, Moons L, De Groef L. Retinal alpha-synuclein deposits in Parkinson\u2019s disease patients and animal models. Acta Neuropathol. 2019;137(3):379\u201395. https:\/\/doi.org\/10.1007\/s00401-018-01956-z.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"4520_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/NEN.0b013e31820376cc","volume":"70","author":"F Leger","year":"2011","unstructured":"Leger F, Fernagut PO, Canron MH, Leoni S, Vital C, Tison F, Bezard E, Vital A. Protein aggregation in the aging retina. J Neuropathol Exp Neurol. 2011;70(1):63\u20138. https:\/\/doi.org\/10.1097\/NEN.0b013e31820376cc.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"4520_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbrc.2007.04.108","volume":"358","author":"M Nakai","year":"2007","unstructured":"Nakai M, Fujita M, Waragai M, Sugama S, Wei J, Akatsu H, Ohtaka-Maruyama C, Okado H, et al. Expression of \u03b1-synuclein, a presynaptic protein implicated in Parkinson\u2019s disease, in erythropoietic lineage. Biochem Bioph Res Co. 2007;358(1):104\u201310. https:\/\/doi.org\/10.1016\/j.bbrc.2007.04.108.","journal-title":"Biochem Bioph Res Co"},{"issue":"12","key":"4520_CR46","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/acn3.50944","volume":"6","author":"ES Abd","year":"2019","unstructured":"Abd ES, Grigoletto J, Poli M, Arosio P, Arkadir D, Sharon R. alpha-Synuclein in blood cells differentiates Parkinson\u2019s disease from healthy controls. Ann Clin Transl Neurol. 2019;6(12):2426\u201336. https:\/\/doi.org\/10.1002\/acn3.50944.","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"4520_CR47","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/brainsci10070466","volume":"10","author":"T Katayama","year":"2020","unstructured":"Katayama T, Sawada J, Takahashi K, Yahara O. Cerebrospinal fluid biomarkers in Parkinson\u2019s disease: a critical overview of the literature and meta-analyses. Brain Sci. 2020;10(7):466. https:\/\/doi.org\/10.3390\/brainsci10070466.","journal-title":"Brain Sci"},{"issue":"4","key":"4520_CR48","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/nan.12524","volume":"45","author":"H Ning","year":"2018","unstructured":"Ning H, Wu Q, Han D, Yao T, Wang J, Lu W, Lv S, Jia Q, et al. Baseline concentration of misfolded \u03b1-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in Parkinson\u2019s disease. Neuropath Appl Neuro. 2018;45(4):398\u2013409. https:\/\/doi.org\/10.1111\/nan.12524.","journal-title":"Neuropath Appl Neuro"},{"key":"4520_CR49","doi-asserted-by":"publisher","first-page":"2138511671","DOI":"10.1177\/1177271920950319","volume":"15","author":"E Camporesi","year":"2020","unstructured":"Camporesi E, Nilsson J, Brinkmalm A, Becker B, Ashton NJ, Blennow K, Zetterberg H. Fluid biomarkers for synaptic dysfunction and loss. Biomarker Insights. 2020;15:2138511671. https:\/\/doi.org\/10.1177\/1177271920950319.","journal-title":"Biomarker Insights"},{"key":"4520_CR50","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neulet.2018.12.030","volume":"696","author":"Z Cao","year":"2018","unstructured":"Cao Z, Wu Y, Liu G, Jiang Y, Wang X, Wang Z, Feng T. \u03b1-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson\u2019s disease. Neurosci Lett. 2018;696:114\u201320. https:\/\/doi.org\/10.1016\/j.neulet.2018.12.030.","journal-title":"Neurosci Lett"},{"key":"4520_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.parkreldis.2019.02.014","volume":"63","author":"G Vivacqua","year":"2019","unstructured":"Vivacqua G, Suppa A, Mancinelli R, Belvisi D, Fabbrini A, Costanzo M, Formica A, Onori P, et al. Salivary alpha-synuclein in the diagnosis of Parkinson\u2019s disease and progressive supranuclear palsy. Parkinsonism Relat D. 2019;63:143\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.014.","journal-title":"Parkinsonism Relat D"},{"issue":"Suppl 2","key":"4520_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40120-019-00168-1","volume":"8","author":"NJ Ashton","year":"2019","unstructured":"Ashton NJ, Ide M, Zetterberg H, Blennow K. Salivary biomarkers for Alzheimer\u2019s disease and related disorders. Neurol Ther. 2019;8(Suppl 2):83\u201394. https:\/\/doi.org\/10.1007\/s40120-019-00168-1.","journal-title":"Neurol Ther"},{"issue":"3","key":"4520_CR53","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3233\/JPD-201983","volume":"10","author":"D Nam","year":"2020","unstructured":"Nam D, Lee J, Lee M, Kim J, Seol W, Son I, Ho DH. Detection and assessment of \u03b1-synuclein oligomers in the urine of Parkinson\u2019s disease patients. J Parkinsons Dis. 2020;10(3):981\u201391. https:\/\/doi.org\/10.3233\/JPD-201983.","journal-title":"J Parkinsons Dis"},{"issue":"27","key":"4520_CR54","doi-asserted-by":"publisher","first-page":"7669","DOI":"10.1007\/s00216-016-9863-7","volume":"408","author":"S Abd-Elhadi","year":"2016","unstructured":"Abd-Elhadi S, Basora M, Vilas D, Tolosa E, Sharon R. Total \u03b1-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA. Anal Bioanal Chem. 2016;408(27):7669\u201377. https:\/\/doi.org\/10.1007\/s00216-016-9863-7.","journal-title":"Anal Bioanal Chem"},{"issue":"12","key":"4520_CR55","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1039\/c2sc21221h","volume":"3","author":"T Bryan","year":"2012","unstructured":"Bryan T, Luo X, Forsgren L, Morozova-Roche LA, Davis JJ. The robust electrochemical detection of a Parkinson\u2019s disease marker in whole blood sera. Chem Sci (Cambridge). 2012;3(12):3468\u201373. https:\/\/doi.org\/10.1039\/c2sc21221h.","journal-title":"Chem Sci (Cambridge)"},{"issue":"1","key":"4520_CR56","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1021\/ac503890e","volume":"87","author":"Q Xu","year":"2014","unstructured":"Xu Q, Cheng H, Lehr J, Patil AV, Davis JJ. Graphene oxide interfaces in serum based autoantibody quantification. Anal Chem. 2014;87(1):346\u201350. https:\/\/doi.org\/10.1021\/ac503890e.","journal-title":"Anal Chem"},{"key":"4520_CR57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bios.2018.09.081","volume":"123","author":"SM Taghdisi","year":"2018","unstructured":"Taghdisi SM, Danesh NM, Nameghi MA, Ramezani M, Alibolandi M, Hassanzadeh-Khayat M, Emrani AS, Abnous K. A novel electrochemical aptasensor based on nontarget-induced high accumulation of methylene blue on the surface of electrode for sensing of \u03b1-synuclein oligomer. Biosens Bioelectron. 2018;123:14\u20138. https:\/\/doi.org\/10.1016\/j.bios.2018.09.081.","journal-title":"Biosens Bioelectron"},{"issue":"6","key":"4520_CR58","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1039\/D0AN00169D","volume":"145","author":"Q Wu","year":"2020","unstructured":"Wu Q, Tan R, Mi X, Tu Y. Electrochemiluminescent aptamer-sensor for alpha synuclein oligomer based on a metal-organic framework. Analyst. 2020;145(6):2159\u201367. https:\/\/doi.org\/10.1039\/D0AN00169D.","journal-title":"Analyst"},{"key":"4520_CR59","doi-asserted-by":"publisher","unstructured":"Ge CY, Rahman MM, Zhang W, Lopa NS, Jin L, Yoon S, Jang H, Xu GR et al. An electrochemical immunosensor based on a self-assembled monolayer modified electrode for label-free detection of alpha-synuclein. Sensors (Basel). 2020;20(3). https:\/\/doi.org\/10.3390\/s20030617.","DOI":"10.3390\/s20030617"},{"key":"4520_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.aca.2019.09.013","volume":"1089","author":"Q Hassan","year":"2019","unstructured":"Hassan Q, Li S, Ferrag C, Kerman K. Electrochemical biosensors for the detection and study of \u03b1-synuclein related to Parkinson\u2019s disease \u2013 a review. Anal Chim Acta. 2019;1089:32\u20139. https:\/\/doi.org\/10.1016\/j.aca.2019.09.013.","journal-title":"Anal Chim Acta"},{"issue":"2","key":"4520_CR61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jelechem.2010.07.015","volume":"648","author":"T Chan","year":"2010","unstructured":"Chan T, Chow AM, Tang DWF, Li Q, Wang X, Brown IR, Kerman K. Interaction of baicalein and copper with \u03b1-synuclein: electrochemical approach to Parkinson\u2019s disease. J Electroanal Chem. 2010;648(2):151\u20135. https:\/\/doi.org\/10.1016\/j.jelechem.2010.07.015.","journal-title":"J Electroanal Chem"},{"issue":"2","key":"4520_CR62","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1039\/c8an01279b","volume":"144","author":"KM Sonuc","year":"2019","unstructured":"Sonuc KM, Sezginturk MK. Cerebrospinal fluid levels of alpha-synuclein measured using a poly-glutamic acid-modified gold nanoparticle-doped disposable neuro-biosensor system. Analyst. 2019;144(2):611\u201321. https:\/\/doi.org\/10.1039\/c8an01279b.","journal-title":"Analyst"},{"issue":"4","key":"4520_CR63","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3233\/JPD-130247","volume":"3","author":"JL Eberling","year":"2013","unstructured":"Eberling JL, Dave KD, Frasier MA. \u03b1-Synuclein imaging: a critical need for Parkinson\u2019s disease research. J Parkinsons Dis. 2013;3(4):565\u20137. https:\/\/doi.org\/10.3233\/JPD-130247.","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"4520_CR64","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/aps.2015.155","volume":"37","author":"MM Xu","year":"2016","unstructured":"Xu MM, Ren WM, Tang XC, Hu YH, Zhang HY. Advances in development of fluorescent probes for detecting amyloid-beta aggregates. Acta Pharmacol Sin. 2016;37(6):719\u201330. https:\/\/doi.org\/10.1038\/aps.2015.155.","journal-title":"Acta Pharmacol Sin"},{"issue":"49","key":"4520_CR65","doi-asserted-by":"publisher","first-page":"18651","DOI":"10.1021\/ja409709x","volume":"135","author":"JM Goldberg","year":"2013","unstructured":"Goldberg JM, Batjargal S, Chen BS, Petersson EJ. Thioamide quenching of fluorescent probes through photoinduced electron transfer: mechanistic studies and applications. J Am Chem Soc. 2013;135(49):18651\u20138. https:\/\/doi.org\/10.1021\/ja409709x.","journal-title":"J Am Chem Soc"},{"issue":"2","key":"4520_CR66","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0003-2697(89)90046-8","volume":"177","author":"H Naiki","year":"1989","unstructured":"Naiki H, Higuchi K, Hosokawa M, Takeda T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin-T1. Anal Biochem. 1989;177(2):244\u20139. https:\/\/doi.org\/10.1016\/0003-2697(89)90046-8.","journal-title":"Anal Biochem"},{"issue":"7","key":"4520_CR67","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","volume":"1804","author":"M Biancalana","year":"2010","unstructured":"Biancalana M, Koide S. Molecular mechanism of thioflavin-T binding to amyloid fibrils. Bba-Bioenergetics. 2010;1804(7):1405\u201312. https:\/\/doi.org\/10.1016\/j.bbapap.2010.04.001.","journal-title":"Bba-Bioenergetics"},{"key":"4520_CR68","doi-asserted-by":"publisher","unstructured":"Celej MS, Jares-Erijman EA, Jovin TM. Fluorescent N-arylaminonaphthalene sulfonate probes for amyloid aggregation of \u03b1-synuclein. Biophys J. 208;94(12):4867\u20134879. https:\/\/doi.org\/10.1529\/biophysj.107.125211.","DOI":"10.1529\/biophysj.107.125211"},{"issue":"6","key":"4520_CR69","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/jnc.15138","volume":"156","author":"N Pravin","year":"2021","unstructured":"Pravin N, Kumar R, Tripathi S, Kumar P, Mohite GM, Navalkar A, Panigrahi R, Singh N, et al. Benzimidazole-based fluorophores for the detection of amyloid fibrils with higher sensitivity than thioflavin-T. J Neurochem. 2021;156(6):1003\u201319. https:\/\/doi.org\/10.1111\/jnc.15138.","journal-title":"J Neurochem"},{"issue":"8","key":"4520_CR70","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1021\/acschemneuro.1c00090","volume":"12","author":"P Gaur","year":"2021","unstructured":"Gaur P, Galkin M, Kurochka A, Ghosh S, Yushchenko DA, Shvadchak VV. Fluorescent probe for selective imaging of \u03b1-synuclein fibrils in living cells. Acs Chem Neurosci. 2021;12(8):1293\u20138. https:\/\/doi.org\/10.1021\/acschemneuro.1c00090.","journal-title":"Acs Chem Neurosci"},{"issue":"18","key":"4520_CR71","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1039\/C9SC04730A","volume":"11","author":"LM Needham","year":"2020","unstructured":"Needham LM, Weber J, Varela JA, Fyfe JWB, Do DT, Xu CK, Tutton L, Cliffe R, et al. ThX-a next-generation probe for the early detection of amyloid aggregates. Chem Sci. 2020;11(18):4578\u201383. https:\/\/doi.org\/10.1039\/C9SC04730A.","journal-title":"Chem Sci"},{"issue":"50","key":"4520_CR72","doi-asserted-by":"publisher","first-page":"13710","DOI":"10.1021\/acs.jpcb.1c07762","volume":"125","author":"F Gorka","year":"2021","unstructured":"Gorka F, Daly S, Pearson CM, Bulovaite E, Zhang YP, Handa A, Grant SGN, Snaddon TN, et al. A comparative study of high-contrast fluorescence lifetime probes for imaging amyloid in tissue. J Phys Chem B. 2021;125(50):13710\u20137. https:\/\/doi.org\/10.1021\/acs.jpcb.1c07762.","journal-title":"J Phys Chem B"},{"issue":"19","key":"4520_CR73","doi-asserted-by":"publisher","first-page":"8406","DOI":"10.1021\/acs.jpclett.0c01549","volume":"11","author":"LM Needham","year":"2020","unstructured":"Needham LM, Weber J, Pearson CM, Do DT, Gorka F, Lyu G, Bohndiek SE, Snaddon TN, Lee SF. A comparative photophysical study of structural modifications of thioflavin T-inspired fluorophores. J Phys Chem Lett. 2020;11(19):8406\u201316. https:\/\/doi.org\/10.1021\/acs.jpclett.0c01549.","journal-title":"J Phys Chem Lett"},{"key":"4520_CR74","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/2051-5960-1-44","volume":"1","author":"S Shi","year":"2013","unstructured":"Shi S, Mitteregger-Kretzschmar G, Giese A, Kretzschmar HA. Establishing quantitative real-time quaking-induced conversion (qRT-QuIC) for highly sensitive detection and quantification of PrPSc in prion-infected tissues. Acta Neuropathol Commun. 2013;1:44. https:\/\/doi.org\/10.1186\/2051-5960-1-44.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"4520_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-022-00311-3","volume":"11","author":"M Bongianni","year":"2022","unstructured":"Bongianni M, Catalan M, Perra D, Fontana E, Janes F, Bertolotti C, et al. Olfactory swab sampling optimization for \u03b1-synuclein aggregate detection in patients with Parkinson\u2019s disease. Transl Neurodegener. 2022;11(1):37. https:\/\/doi.org\/10.1186\/s40035-022-00311-3.","journal-title":"Transl Neurodegener"},{"issue":"21","key":"4520_CR76","doi-asserted-by":"publisher","first-page":"11874","DOI":"10.1002\/anie.202014898","volume":"60","author":"A Bhumkar","year":"2021","unstructured":"Bhumkar A, Magnan C, Lau D, Jun ESW, Dzamko N, Gambin Y, Sierecki E. Single-molecule counting coupled to rapid amplification enables detection of \u03b1-synuclein aggregates in cerebrospinal fluid of Parkinson\u2019s disease patients. Angew Chem Int Ed Engl. 2021;60(21):11874\u201383. https:\/\/doi.org\/10.1002\/anie.202014898.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"3","key":"4520_CR77","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1021\/cn3001203","volume":"4","author":"PK Singh","year":"2013","unstructured":"Singh PK, Kotia V, Ghosh D, Mohite GM, Kumar A, Maji SK. Curcumin modulates \u03b1-synuclein aggregation and toxicity. Acs Chem Neurosci. 2013;4(3):393\u2013407. https:\/\/doi.org\/10.1021\/cn3001203.","journal-title":"Acs Chem Neurosci"},{"issue":"17","key":"4520_CR78","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.0910723107","volume":"107","author":"J Bieschke","year":"2010","unstructured":"Bieschke J, Russ J, Friedrich RP, Ehrnhoefer DE, Wobst H, Neugebauer K, Wanker EE. EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity. Proc Natl Acad Sci. 2010;107(17):7710\u20135. https:\/\/doi.org\/10.1073\/pnas.0910723107.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"4520_CR79","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","volume":"125","author":"J Wagner","year":"2013","unstructured":"Wagner J, Ryazanov S, Leonov A, Levin J, Shi S, Schmidt F, Prix C, Pan-Montojo F, et al. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease. Acta Neuropathol. 2013;125(6):795\u2013813. https:\/\/doi.org\/10.1007\/s00401-013-1114-9.","journal-title":"Acta Neuropathol"},{"key":"4520_CR80","doi-asserted-by":"publisher","unstructured":"Needham LM, Weber J, Fyfe JWB, Kabia OM, Do DT, Klimont E, Zhang Y, Rodrigues M, Dobson CM, Ghandi S, Bohndiek SE, Snaddon TN, Lee SF. Correction to bifunctional fluorescent probes for detection of amyloid aggregates and reactive oxygen species. R Soc Open Sci. 2018;5(2):171399. https:\/\/doi.org\/10.1098\/rsos.180308.","DOI":"10.1098\/rsos.180308"},{"issue":"15","key":"4520_CR81","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1016\/j.bmc.2012.06.023","volume":"20","author":"L Yu","year":"2012","unstructured":"Yu L, Cui J, Padakanti PK, Engel L, Bagchi DP, Kotzbauer PT, Tu Z. Synthesis and in vitro evaluation of \u03b1-synuclein ligands. Bioorgan Med Chem. 2012;20(15):4625\u201334. https:\/\/doi.org\/10.1016\/j.bmc.2012.06.023.","journal-title":"Bioorgan Med Chem"},{"issue":"6","key":"4520_CR82","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s10895-012-1081-x","volume":"22","author":"VB Kovalska","year":"2012","unstructured":"Kovalska VB, Losytskyy MY, Tolmachev OI, Slominskii YL, Segers-Nolten GMJ, Subramaniam V, Yarmoluk SM. Tri- and pentamethine cyanine dyes for fluorescent detection of \u03b1-synuclein oligomeric aggregates. J Fluoresc. 2012;22(6):1441\u20138. https:\/\/doi.org\/10.1007\/s10895-012-1081-x.","journal-title":"J Fluoresc"},{"issue":"39","key":"4520_CR83","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.1021\/bi5007833","volume":"53","author":"W Paslawski","year":"2014","unstructured":"Paslawski W, Andreasen M, Nielsen SB, Lorenzen N, Thomsen K, Kaspersen JD, Pedersen JS, Otzen DE. High stability and cooperative unfolding of \u03b1-synuclein oligomers. Biochemistry-US. 2014;53(39):6252\u201363. https:\/\/doi.org\/10.1021\/bi5007833.","journal-title":"Biochemistry-US"},{"issue":"2","key":"4520_CR84","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1042\/BJ20081572","volume":"418","author":"J Lee","year":"2009","unstructured":"Lee J, Lee I, Choe Y, Kang S, Kim HY, Gai W, Hahn J, Paik SR. Real-time analysis of amyloid fibril formation of \u03b1-synuclein using a fibrillation-state-specific fluorescent probe of JC-1. Biochem J. 2009;418(2):311\u201323. https:\/\/doi.org\/10.1042\/BJ20081572.","journal-title":"Biochem J"},{"key":"4520_CR85","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.aca.2020.07.073","volume":"1133","author":"Y Wang","year":"2020","unstructured":"Wang Y, Qiu Y, Sun A, Xiong Y, Tan H, Shi Y, Yu P, Roy G, et al. Dual-functional AIE fluorescent probes for imaging \u03b2-amyloid plaques and lipid droplets. Anal Chim Acta. 2020;1133:109\u201318. https:\/\/doi.org\/10.1016\/j.aca.2020.07.073.","journal-title":"Anal Chim Acta"},{"issue":"21","key":"4520_CR86","doi-asserted-by":"publisher","first-page":"11718","DOI":"10.1021\/acs.chemrev.5b00263","volume":"115","author":"J Mei","year":"2015","unstructured":"Mei J, Leung NLC, Kwok RTK, Lam JWY, Tang BZ. Aggregation-induced emission: together we shine, united we soar. Chem Rev. 2015;115(21):11718\u2013940. https:\/\/doi.org\/10.1021\/acs.chemrev.5b00263.","journal-title":"Chem Rev"},{"issue":"24","key":"4520_CR87","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1021\/acschemneuro.0c00478","volume":"11","author":"NR Marzano","year":"2020","unstructured":"Marzano NR, Wray KM, Johnston CL, Paudel BP, Hong Y, van Oijen A, Ecroyd H. An \u03b1-cyanostilbene derivative for the enhanced detection and imaging of amyloid fibril aggregates. Acs Chem Neurosci. 2020;11(24):4191\u2013202. https:\/\/doi.org\/10.1021\/acschemneuro.0c00478.","journal-title":"Acs Chem Neurosci"},{"issue":"10","key":"4520_CR88","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1039\/C4CC07911F","volume":"51","author":"CW Leung","year":"2015","unstructured":"Leung CW, Guo F, Hong Y, Zhao E, Kwok RT, Leung NL, Chen S, Vaikath NN, El-Agnaf OM, Tang Y, Gai WP, Tang BZ. Detection of oligomers and fibrils of \u03b1-synuclein by AIE-gen with strong fluorescence. ChemComm (Camb). 2015;51(10):1866\u20139. https:\/\/doi.org\/10.1039\/C4CC07911F.","journal-title":"ChemComm (Camb)"},{"issue":"S2","key":"4520_CR89","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/j.rbp.2012.07.002","volume":"34","author":"M Benadiba","year":"2012","unstructured":"Benadiba M, Luurtsema G, Wichert-Ana L, Buchpigel CA, Busatto FG. New molecular targets for PET and SPECT imaging in neurodegenerative diseases. Rev Bras Psiquiatr. 2012;34(S2):S125\u201336. https:\/\/doi.org\/10.1016\/j.rbp.2012.07.002.","journal-title":"Rev Bras Psiquiatr"},{"issue":"2","key":"4520_CR90","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s13311-020-00994-4","volume":"18","author":"DJ Brooks","year":"2021","unstructured":"Brooks DJ. Imaging familial and sporadic neurodegenerative disorders associated with Parkinsonism. Neurotherapeutics. 2021;18(2):753\u201371. https:\/\/doi.org\/10.1007\/s13311-020-00994-4.","journal-title":"Neurotherapeutics"},{"issue":"5 Suppl","key":"4520_CR91","doi-asserted-by":"publisher","first-page":"S395","DOI":"10.1016\/j.jalz.2013.09.007","volume":"10","author":"A Cortes-Blanco","year":"2014","unstructured":"Cortes-Blanco A, Prieto-Yerro C, Martinez-Lazaro R, Zamora J, Jim\u00e9nez-Huete A, Haberkamp M, Pohly J, Enzmann H, Zinserling J, Strassmann V, Broich K. Florbetapir (18F) for brain amyloid positron emission tomography: highlights on the European marketing approval. Alzheimers Dement. 2014;10(5 Suppl):S395\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2013.09.007.","journal-title":"Alzheimers Dement"},{"key":"4520_CR92","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2967\/jnumed.112.114660","volume":"54","author":"A Rominger","year":"2013","unstructured":"Rominger A, Brendel M, Burgold S, Keppler K, Baumann K, Xiong G, et al. Longitudinal assessment of cerebral \u03b2-amyloid deposition in mice overexpressing Swedish mutant \u03b2-amyloid precursor protein using 18F florbetaben PET. J Nucl Med. 2013;54:1127\u201334. https:\/\/doi.org\/10.2967\/jnumed.112.114660.","journal-title":"J Nucl Med"},{"issue":"Suppl 3","key":"4520_CR93","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3233\/JAD-2011-0068","volume":"26","author":"H Barthel","year":"2011","unstructured":"Barthel H, Sabri O. Florbetaben to trace amyloid-\u03b2 in the Alzheimer brain by means of PET. J Alzheimers Dis. 2011;26(Suppl 3):117\u201321. https:\/\/doi.org\/10.3233\/JAD-2011-0068.","journal-title":"J Alzheimers Dis"},{"key":"4520_CR94","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez G, Vernooij RW, Fuentes Padilla P, Zamora J, Flicker L, Bonfill Cosp X. 18F PET with flutemetamol for the early diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2017; 11(11):CD012884. https:\/\/doi.org\/10.1002\/14651858.CD012884.","DOI":"10.1002\/14651858.CD012884"},{"issue":"2","key":"4520_CR95","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","volume":"7","author":"D Skovronsky","year":"2008","unstructured":"Skovronsky D, Dyrks T, Holl G, Krause S, Friebe M, Lehman L, Lindemann S, Dinkelborg LM, Masters CL, Villemagne VL. Imaging of amyloid beta in Alzheimer\u2019s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 2008;7(2):129\u201335. https:\/\/doi.org\/10.1016\/S1474-4422(08)70001-2.","journal-title":"Lancet Neurol"},{"issue":"9","key":"4520_CR96","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2967\/jnumed.113.136515","volume":"55","author":"M Shah","year":"2014","unstructured":"Shah M, Seibyl J, Cartier A, Bhatt R, Catafau AM. Molecular imaging insights into neurodegeneration: focus on alpha-synuclein radiotracers. J Nucl Med. 2014;55(9):1397\u2013400. https:\/\/doi.org\/10.2967\/jnumed.113.136515.","journal-title":"J Nucl Med"},{"issue":"3","key":"4520_CR97","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer\u2019s disease with pittsburgh compound-B. Ann Neurol. 2004;55(3):306\u201319. https:\/\/doi.org\/10.1002\/ana.20009.","journal-title":"Ann Neurol"},{"issue":"1\u20133","key":"4520_CR98","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejphar.2009.06.042","volume":"617","author":"MT Fodero-Tavoletti","year":"2009","unstructured":"Fodero-Tavoletti MT, Mulligan RS, Okamura N, Furumoto S, Rowe CC, Kudo Y, Masters CL, Cappai R, et al. In vitro characterisation of BF227 binding to \u03b1-synuclein\/Lewy bodies. Eur J Pharmacol. 2009;617(1\u20133):54\u20138. https:\/\/doi.org\/10.1016\/j.ejphar.2009.06.042.","journal-title":"Eur J Pharmacol"},{"key":"4520_CR99","doi-asserted-by":"publisher","first-page":"296472781","DOI":"10.1177\/1536012118796297","volume":"17","author":"L Josephson","year":"2018","unstructured":"Josephson L, Stratman N, Liu Y, Qian F, Liang SH, Vasdev N, Patel S. The binding of BF-227-like benzoxazoles to human \u03b1-synuclein and amyloid \u03b2 peptide fibrils. Mol Imaging. 2018;17:296472781. https:\/\/doi.org\/10.1177\/1536012118796297.","journal-title":"Mol Imaging"},{"issue":"6","key":"4520_CR100","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/mds.27013","volume":"32","author":"S Koga","year":"2017","unstructured":"Koga S, Ono M, Sahara N, Higuchi M, Dickson DW. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to \u03b1-synuclein pathology. Mov Disord. 2017;32(6):884\u201392. https:\/\/doi.org\/10.1002\/mds.27013.","journal-title":"Mov Disord"},{"issue":"4","key":"4520_CR101","first-page":"266","volume":"2","author":"H Fujishiro","year":"2013","unstructured":"Fujishiro H, Imamura AY, Lin WL, Uchikado H, Mark MH, Golbe LI, Markopoulou K, Wszolek ZK, et al. Diversity of pathological features other than Lewy bodies in familial Parkinson\u2019s disease due to SNCA mutations. Am J Neurodegener Dis. 2013;2(4):266-275.","journal-title":"Am J Neurodegener Dis"},{"key":"4520_CR102","doi-asserted-by":"publisher","unstructured":"Bagchi DP, Yu L, Perlmutter JS, Xu J, Mach RH, Tu Z, Kotzbauer PT. Binding of the radioligand SIL23 to \u03b1-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent. PLoS ONE. 2013;8(2): e55031. https:\/\/doi.org\/10.1371\/journal.pone.0055031.","DOI":"10.1371\/journal.pone.0055031"},{"issue":"1","key":"4520_CR103","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/app4010066","volume":"4","author":"X Zhang","year":"2014","unstructured":"Zhang X, Jin H, Padakanti P, Li J, Yang H, Fan J, Mach R, Kotzbauer P, et al. Radiosynthesis and in vivo evaluation of two PET radioligands for imaging \u03b1-synuclein. Appl Sci. 2014;4(1):66\u201378. https:\/\/doi.org\/10.3390\/app4010066.","journal-title":"Appl Sci"},{"key":"4520_CR104","doi-asserted-by":"publisher","first-page":"6002","DOI":"10.1021\/acs.jmedchem.5b00571","volume":"58","author":"W Chu","year":"2015","unstructured":"Chu W, Zhou D, Gaba V, Liu J, Li S, Peng X, et al. Design, synthesis, and characterization of 3-(Benzylidene) indolin-2-one derivatives as ligands for \u03b1-synuclein fibrils. J Med Chem. 2015;58:6002\u201317. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00571.","journal-title":"J Med Chem"},{"issue":"6","key":"4520_CR105","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.bmcl.2018.02.031","volume":"28","author":"X Yue","year":"2018","unstructured":"Yue X, Dhavale DD, Li J, Luo Z, Liu J, Yang H, Mach RH, Kotzbauer PT, Tu Z. Design, synthesis, and in vitro evaluation of quinolinyl analogues for \u03b1-synuclein aggregation. Bioorg Med Chem Lett. 2018;28(6):1011\u20139. https:\/\/doi.org\/10.1016\/j.bmcl.2018.02.031.","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"4520_CR106","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/cmdc.201900689","volume":"15","author":"A Maurer","year":"2020","unstructured":"Maurer A, Leonov A, Ryazanov S, Herfert K, Kuebler L, Buss S, Schmidt F, Weckbecker D, et al. 11C Radiolabeling of anle253b: a putative PET tracer for Parkinson\u2019s disease that binds to \u03b1-synuclein fibrils in vitro and crosses the blood-brain barrier. ChemMedChem. 2020;15(5):411\u20135. https:\/\/doi.org\/10.1002\/cmdc.201900689.","journal-title":"ChemMedChem"},{"key":"4520_CR107","unstructured":"Hooshyar Yousefi B, Shi K, Reder S, Reder S, Herz M, Braeuer M, et al. First in vivo imaging and in vitro studies of 18F-DABTA in rat model with E46K alpha synuclein mutation. Eur J Nucl Med Mol Imaging. USA: SPRINGER. 2017;44(Suppl 2):161."},{"issue":"10","key":"4520_CR108","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00259-018-4029-9","volume":"45","author":"S Fanti","year":"2018","unstructured":"Fanti S, Bonfiglioli R, Decristoforo C. Highlights of the 30th annual congress of the EANM, Vienna 2017: \u201cYes we can\u2013make nuclear medicine great again.\u201d Eur J Nucl Med Mol I. 2018;45(10):1781\u201394. https:\/\/doi.org\/10.1007\/s00259-018-4029-9.","journal-title":"Eur J Nucl Med Mol I"},{"key":"4520_CR109","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2010.2008","volume":"305","author":"CM Clark","year":"2011","unstructured":"Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011;305:275\u201383. https:\/\/doi.org\/10.1001\/jama.2010.2008.","journal-title":"JAMA"},{"issue":"1","key":"4520_CR110","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40336-015-0102-6","volume":"3","author":"O Sabri","year":"2015","unstructured":"Sabri O, Seibyl J, Rowe C, Barthel H. Beta-amyloid imaging with florbetaben. Clin Transl Imaging. 2015;3(1):13\u201326. https:\/\/doi.org\/10.1007\/s40336-015-0102-6.","journal-title":"Clin Transl Imaging"},{"key":"4520_CR111","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s00259-012-2178-9","volume":"39","author":"A Snellman","year":"2012","unstructured":"Snellman A, Rokka J, Lopez-Picon FR, Eskola O, Wilson I, Farrar G, et al. Pharmacokinetics of [18F] flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2012;39:1784\u201395. https:\/\/doi.org\/10.1007\/s00259-012-2178-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4520_CR112","doi-asserted-by":"publisher","first-page":"10598","DOI":"10.1523\/JNEUROSCI.2990-05.2005","volume":"25","author":"WE Klunk","year":"2005","unstructured":"Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer\u2019s disease brain but not in transgenic mouse brain. J Neurosci. 2005;25:10598\u2013606. https:\/\/doi.org\/10.1523\/JNEUROSCI.2990-05.2005.","journal-title":"J Neurosci"},{"key":"4520_CR113","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2174\/1567205011666141107154201","volume":"11","author":"E Levigoureux","year":"2014","unstructured":"Levigoureux E, Lancelot S, Bouillot C, Chauveau F, Verdurand M, Verchere J, et al. Binding of the PET radiotracer [18F]BF227 does not reflect the presence of alpha-synuclein aggregates in transgenic mice. Curr Alzheimer Res. 2014;11:955\u201360.","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"4520_CR114","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/mds.27029","volume":"32","author":"A Perez-Soriano","year":"2017","unstructured":"Perez-Soriano A, Arena JE, Dinelle K, Miao Q, McKenzie J, Neilson N, Puschmann A, Schaffer P, Shinotoh H, Smith-Forrester J, Shahinfard E, Vafai N, Wile D, Wszolek Z, Higuchi M, Sossi V, Stoessl AJ. PBB3 imaging in Parkinsonian disorders: evidence for binding to tau and other proteins. Mov Disord. 2017;32(7):1016\u201324. https:\/\/doi.org\/10.1002\/mds.27029.","journal-title":"Mov Disord"},{"key":"4520_CR115","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s00259-017-3704-6","volume":"44","author":"E Aboagye","year":"2017","unstructured":"Aboagye E, Kraeber-Bod\u00e9r\u00e9 F. Highlights lecture EANM 2016: \u201cEmbracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine.\u201d Eur J Nucl Med Mol Imaging. 2017;44:1559\u201374. https:\/\/doi.org\/10.1007\/s00259-017-3704-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4520_CR116","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/bs.irn.2018.08.008","volume":"141","author":"T Yousaf","year":"2018","unstructured":"Yousaf T, Dervenoulas G, Politis M. Advances in MRI methodology. Int Rev Neurobiol. 2018;141:31\u201376. https:\/\/doi.org\/10.1016\/bs.irn.2018.08.008.","journal-title":"Int Rev Neurobiol"},{"key":"4520_CR117","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/bs.irn.2018.10.007","volume":"144","author":"O Cousins","year":"2019","unstructured":"Cousins O, Yousaf T, Wilson H, Pagano G, Politis M. Molecular imaging of dementia with Lewy bodies. Int Rev Neurobiol. 2019;144:59\u201393. https:\/\/doi.org\/10.1016\/bs.irn.2018.10.007.","journal-title":"Int Rev Neurobiol"},{"issue":"12","key":"4520_CR118","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrneurol.2014.205","volume":"10","author":"M Politis","year":"2014","unstructured":"Politis M. Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol. 2014;10(12):708\u201322. https:\/\/doi.org\/10.1038\/nrneurol.2014.205.","journal-title":"Nat Rev Neurol"},{"key":"4520_CR119","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbi.2016.11.027","volume":"61","author":"A Khairnar","year":"2017","unstructured":"Khairnar A, Ruda-Kucerova J, Szab\u00f3 N, Drazanova E, Arab A, Hutter-Paier B, Neddens J, Latta P, Starcuk ZJ, Rektorova I. Early and progressive microstructural brain changes in mice overexpressing human \u03b1-synuclein detected by diffusion kurtosis imaging. Brain Behav Immun. 2017;61:197\u2013208. https:\/\/doi.org\/10.1016\/j.bbi.2016.11.027.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"4520_CR120","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41591-020-01198-1","volume":"27","author":"XB Ding","year":"2021","unstructured":"Ding XB, Wang XB, Xia DH, Liu H, Tian HY, Fu Y, Chen YK, Qin C, Wang JQ, Xiang Z, Zhang ZX, Cao QC, Wang W, Li JY, Wu E, Tang BS, Ma MM, Teng JF, Wang XJ. Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson\u2019s disease. Nat Med. 2021;27(3):411\u20138. https:\/\/doi.org\/10.1038\/s41591-020-01198-1.","journal-title":"Nat Med"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-023-04520-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-023-04520-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-023-04520-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T07:04:50Z","timestamp":1678172690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-023-04520-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":120,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["4520"],"URL":"https:\/\/doi.org\/10.1007\/s00216-023-04520-1","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"21 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors mentioned have participated in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors approved the publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}